6533b826fe1ef96bd1283e3a

RESEARCH PRODUCT

Computing Metal-Binding Proteins for Therapeutic Benefit

Angelo SpinelloMatic PavlinPavel JanošJure BorišekAlessandra Magistrato

subject

Functional roleModels MolecularMetalloenzymesCellular functionsMetallo enzymeMolecular ConformationComputational biologyMolecular Dynamics01 natural sciencesBiochemistryQM/MMDockingMetals HeavyDrug DiscoveryBiochemical reactionsMetal transportersGeneral Pharmacology Toxicology and PharmaceuticsPharmacology010405 organic chemistryOrganic ChemistryComputational BiologyMetal binding proteins0104 chemical sciences010404 medicinal & biomolecular chemistryDocking (molecular)Settore CHIM/03 - Chimica Generale E InorganicaMolecular MedicineCarrier Proteins

description

Over one third of biomolecules rely on metal ions to exert their cellular functions. Metal ions can play a structural role by stabilizing the structure of biomolecules, a functional role by promoting a wide variety of biochemical reactions, and a regulatory role by acting as messengers upon binding to proteins regulating cellular metal-homeostasis. These diverse roles in biology ascribe critical implications to metal-binding proteins in the onset of many diseases. Hence, it is of utmost importance to exhaustively unlock the different mechanistic facets of metal-binding proteins and to harness this knowledge to rationally devise novel therapeutic strategies to prevent or cure pathological states associated with metal-dependent cellular dysfunctions. In this compendium, we illustrate how the use of a computational arsenal based on docking, classical, and quantum-classical molecular dynamics simulations can contribute to extricate the minutiae of the catalytic, transport, and inhibition mechanisms of metal-binding proteins at the atomic level. This knowledge represents a fertile ground and an essential prerequisite for selectively targeting metal-binding proteins with small-molecule inhibitors aiming to (i) abrogate deregulated metal-dependent (mis)functions or (ii) leverage metal-dyshomeostasis to selectively trigger harmful cells death.

10.1002/cmdc.202100109http://hdl.handle.net/10447/535283